Literature DB >> 19898200

Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4+CD127-/lo T cells.

Alan F Zahorchak1, Giorgio Raimondi, Angus W Thomson.   

Abstract

BACKGROUND: Generation of non-human primate regulatory T cells (Treg) with alloantigen (alloAg) specificity would allow their testing in preclinical transplant models. Low recovery of Treg from peripheral blood limits their potential utility. In small animals and humans, conventional myeloid dendritic cells (DC) have been shown to select or induce alloAg-specific Treg.
METHODS: We combined enrichment of rhesus macaque blood CD4 Treg based on IL-7Ralpha (CD127) expression with their stimulation in mixed leukocyte cultures with immature, allogeneic control or vitamin (Vit) D3/IL-10-conditioned monocyte-derived DC. After co-culture in IL-2 and IL-15 for up to 14 days, the ability of the resulting T cells to suppress alloreactive effector T-cell proliferation was assessed.
RESULTS: CD4CD127 T cells represented approximately 7% of normal rhesus circulating CD4 T cells and were enriched for forkhead box P3 (Foxp3) cells. When stimulated with control allogeneic DC, they exhibited much inferior proliferative responses compared with bulk CD4 or CD4CD127 cells. This anergic state was reversed by exogenous IL-2 and IL-15. After 10 to 14 days culture of CD4CD127 T cells with immature allogeneic DC, particularly maturation-resistant VitD3/IL-10 DC, the frequency of Foxp3 T cells was increased. The cultured cells markedly inhibited CD4 effector T-cell proliferation in a dose-related and donor alloAg-specific manner.
CONCLUSION: Stimulation of rhesus CD4CD127 T cells with immature and especially maturation-resistant allogeneic DC, generated highly-suppressive, alloAg-specific Treg. Without resorting to a more purified starting population, this approach may have therapeutic utility in clinically relevant transplant models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898200      PMCID: PMC2775499          DOI: 10.1097/TP.0b013e3181ba6b1f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  44 in total

1.  CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.

Authors:  Cherry I Kingsley; Mahzuz Karim; Andrew R Bushell; Kathryn J Wood
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 2.  Regulatory T cells in transplantation tolerance.

Authors:  Kathryn J Wood; Shimon Sakaguchi
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

3.  Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses.

Authors:  A Anderson; C L Martens; R Hendrix; L L Stempora; W P Miller; K Hamby; M Russell; E Strobert; B R Blazar; T C Pearson; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2008-09-17       Impact factor: 8.086

4.  1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.

Authors:  G Penna; L Adorini
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo.

Authors:  Holger Hackstein; Timucin Taner; Alan F Zahorchak; Adrian E Morelli; Alison J Logar; Andre Gessner; Angus W Thomson
Journal:  Blood       Date:  2003-01-16       Impact factor: 22.113

7.  Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

Authors:  Aurélie Trenado; Frédéric Charlotte; Sylvain Fisson; Micael Yagello; David Klatzmann; Benoit L Salomon; José L Cohen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

Authors:  Shuiping Jiang; Niels Camara; Giovanna Lombardi; Robert I Lechler
Journal:  Blood       Date:  2003-05-29       Impact factor: 22.113

Review 9.  Crossing the bridge: large animal models in translational transplantation research.

Authors:  Allan D Kirk
Journal:  Immunol Rev       Date:  2003-12       Impact factor: 12.988

Review 10.  Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

Authors:  Luciano Adorini; Giuseppe Penna; Nadia Giarratana; Milan Uskokovic
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

View more
  8 in total

Review 1.  Non-human primate regulatory T cells: current biology and implications for transplantation.

Authors:  Eefje M Dons; Giorgio Raimondi; David K C Cooper; Angus W Thomson
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

Review 2.  Tolerogenic dendritic cells and their role in transplantation.

Authors:  Mohamed Ezzelarab; Angus W Thomson
Journal:  Semin Immunol       Date:  2011-07-07       Impact factor: 11.130

Review 3.  Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.

Authors:  Adrian E Morelli; Angus W Thomson
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

4.  Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells.

Authors:  Pietro Presicce; Julia M Shaw; Christopher J Miller; Barbara L Shacklett; Claire A Chougnet
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

Review 5.  Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation.

Authors:  Angus W Thomson; Mohamed B Ezzelarab
Journal:  Cell Immunol       Date:  2020-03-12       Impact factor: 4.868

6.  Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.

Authors:  M B Ezzelarab; A F Zahorchak; L Lu; A E Morelli; G Chalasani; A J Demetris; F G Lakkis; M Wijkstrom; N Murase; A Humar; R Shapiro; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2013-06-11       Impact factor: 8.086

Review 7.  Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease.

Authors:  Sara Ness; Shiming Lin; John R Gordon
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

8.  TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation.

Authors:  Huan-Ping Zhang; Yingying Wu; Jiangqi Liu; Jing Jiang; Xiao-Rui Geng; Gui Yang; Lihua Mo; Zhi-Qiang Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Sci Rep       Date:  2013-11-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.